Fresenius is a global healthcare company headquartered in Bad Homburg v. d. Höhe, Germany. In fiscal year 2022, Fresenius generated €21.5 billion in annual revenue with around 190,000 employees (excluding Fresenius Medical Care). As a healthcare company focused on therapy, Fresenius offers system-critical products and services for leading therapies for the care of critically and chronically ill patients.
The Fresenius Group comprises the Operating Companies Fresenius Kabi and Fresenius Helios as well as the Investment Companies Fresenius Medical Care and Fresenius Vamed.
- Fresenius Kabi supplies healthcare products for critically and chronically ill patients
- Fresenius Helios is Europe’s leading private hospital operator
- Fresenius Vamed specializes on project business and management of healthcare facilities
Fresenius continuously develops its business areas. With the #FutureFresenius program, the focus will be on three therapy platforms:
- (Bio)Pharma including clinical nutrition
- Care Provision
With these platforms, Fresenius caters to major trends in healthcare and becomes a more therapy-focused company. The health and quality of life of patients who the company serves with high-quality, affordable products and services is at the core.
At Fresenius, the patient always comes first. For more than 100 years now we have been working to save lives and improve the quality of life of our critically and chronically ill patients. A clear focus on innovation and efficiency has helped us to make world-class therapies accessible to a steadily increasing number of people. Yet we never get complacent about our successes, and never stop looking for better solutions. This is how Fresenius is contributing to medical progress and better patient care.
Success in our business is the key for investing in high-quality yet affordable healthcare. In this way we are meeting our social responsibility to help patients, while ensuring that Fresenius remains successful over the long term. As a global healthcare group with a diverse workforce, we are committed to an open and pluralistic society. We are convinced that extremism, populism and intolerance threaten the free and democratic basic order, our way of life and our prosperity.
Fresenius leads by recognizing important trends and developments early, then working with our partners to help shape healthcare systems. Aging populations and the expansion of healthcare provision in countries worldwide are driving demand for medical products and services, and Fresenius is excellently positioned for continuous and profitable growth in the future.
“Advancing patient care” – we strive to improve continuously and to shape the future of healthcare as an industry-leading, therapy-focused healthcare company.
Fresenius SE & Co. KGaA
61352 Bad Homburg
T: +49 6172 608-0